House of Lords Business
Show full summary

Lord Mendelsohn to ask His Majesty's Government what steps they are taking to ensure that future new treatments for COVID-19 for clinically vulnerable people are (1) evaluated, and (2) delivered, along the same timeline as vaccines; and which body will be responsible for that process once Medicines and Healthcare products Regulatory Agency (MHRA) approval is granted. 

Question HL5218: tabled on 30 January 2023 and due for answer by 13 February 2023

This type of business sits within the Questions & Statements category.

This question has been answered by the relevant Government Department.

Question text

Lord Mendelsohn to ask His Majesty's Government what steps they are taking to ensure that future new treatments for COVID-19 for clinically vulnerable people are (1) evaluated, and (2) delivered, along the same timeline as vaccines; and which body will be responsible for that process once Medicines and Healthcare products Regulatory Agency (MHRA) approval is granted.  HL5218
Legend for business item text
† Item that is new or altered.
* Item is an oral question.
Numbers starting HL are unique identifiers for written questions, Bills or papers.

Date Answered

Tuesday 7 February 2023

Member's Registered Interests

There are no interests to show.

Main Member

Lord Mendelsohn
Labour
Life peer